{[2-Hydroxy-1,1-bis(hydroxymethyl)ethyl]ammonio}acetate

Details

Top
Internal ID 8d03c59f-d9be-4616-b2bc-e3cf9914596d
Taxonomy Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Alpha amino acids and derivatives > Alpha amino acids
IUPAC Name 2-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azaniumyl]acetate
SMILES (Canonical) C(C(=O)[O-])[NH2+]C(CO)(CO)CO
SMILES (Isomeric) C(C(=O)[O-])[NH2+]C(CO)(CO)CO
InChI InChI=1S/C6H13NO5/c8-2-6(3-9,4-10)7-1-5(11)12/h7-10H,1-4H2,(H,11,12)
InChI Key SEQKRHFRPICQDD-UHFFFAOYSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C6H13NO5
Molecular Weight 179.17 g/mol
Exact Mass 179.07937252 g/mol
Topological Polar Surface Area (TPSA) 117.00 Ų
XlogP -4.40
Atomic LogP (AlogP) -4.98
H-Bond Acceptor 5
H-Bond Donor 4
Rotatable Bonds 6

Synonyms

Top
{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]ammonio}acetate
SCHEMBL42019
N-tris(hydroxymethyl)methylammonioacetate
N-[tris(hydroxymethyl)methyl]glycine or N-(2-hydroxy-1,1-bis[hydroxymethyl]ethyl)glycine

2D Structure

Top
2D Structure of {[2-Hydroxy-1,1-bis(hydroxymethyl)ethyl]ammonio}acetate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.7078 70.78%
Caco-2 - 0.6454 64.54%
Blood Brain Barrier - 0.5250 52.50%
Human oral bioavailability + 0.6286 62.86%
Subcellular localzation Lysosomes 0.7555 75.55%
OATP2B1 inhibitior - 0.8559 85.59%
OATP1B1 inhibitior + 0.9373 93.73%
OATP1B3 inhibitior + 0.9115 91.15%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9669 96.69%
P-glycoprotein inhibitior - 0.9784 97.84%
P-glycoprotein substrate - 0.9668 96.68%
CYP3A4 substrate - 0.7163 71.63%
CYP2C9 substrate - 0.8070 80.70%
CYP2D6 substrate - 0.8375 83.75%
CYP3A4 inhibition - 0.9563 95.63%
CYP2C9 inhibition - 0.9244 92.44%
CYP2C19 inhibition - 0.8790 87.90%
CYP2D6 inhibition - 0.8926 89.26%
CYP1A2 inhibition - 0.7082 70.82%
CYP2C8 inhibition - 0.9790 97.90%
CYP inhibitory promiscuity - 0.9839 98.39%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9000 90.00%
Carcinogenicity (trinary) Non-required 0.5990 59.90%
Eye corrosion - 0.9758 97.58%
Eye irritation + 0.9812 98.12%
Skin irritation - 0.7667 76.67%
Skin corrosion - 0.9485 94.85%
Ames mutagenesis - 0.6254 62.54%
Human Ether-a-go-go-Related Gene inhibition - 0.7909 79.09%
Micronuclear - 0.5600 56.00%
Hepatotoxicity - 0.5375 53.75%
skin sensitisation - 0.9386 93.86%
Respiratory toxicity - 0.8333 83.33%
Reproductive toxicity - 0.7516 75.16%
Mitochondrial toxicity + 0.6125 61.25%
Nephrotoxicity + 0.4882 48.82%
Acute Oral Toxicity (c) III 0.4964 49.64%
Estrogen receptor binding - 0.8989 89.89%
Androgen receptor binding - 0.9217 92.17%
Thyroid receptor binding - 0.8916 89.16%
Glucocorticoid receptor binding - 0.8745 87.45%
Aromatase binding - 0.7212 72.12%
PPAR gamma - 0.8224 82.24%
Honey bee toxicity - 0.9015 90.15%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity - 0.7300 73.00%
Fish aquatic toxicity - 0.9388 93.88%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 89.50% 96.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 82.28% 94.45%
CHEMBL3060 Q9Y345 Glycine transporter 2 80.97% 99.17%

Cross-Links

Top
PubChem 6992779
NPASS NPC225404